Carina Lynn Gehlert

This paper introduces a multifunctional fusion protein that enables efficient ex vivo expansion of NK cells from various sources and enhances their cytotoxic activity against tumor cells.

This paper evaluates a novel Fc-optimized antibody drug conjugate targeting CD7, showing potent anti-leukemia activity in preclinical T-ALL models.

This study shows CD20 stabilizes CD37 on B-cell lymphoma cells, affecting anti-CD37 therapy efficacy, but not CAR-T cell effectiveness.